CVE-2004-2020

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in Php-Nuke 6.x through 7.3 allow remote attackers to inject arbitrary HTML or web script into the (1) optionbox parameter in the News module, (2) date parameter in the Statistics module, (3) year, month, and month_1 parameters in the Stories_Archive module, (4) mode, order, and thold parameters in the Surveys module, or (5) a SQL statement to index.php, as processed by mainfile.php.

4.3

CVSS

Severity: Medium

CVSS 2.0 •

EPSS 0.04%

Third-Party Advisory secunia.com

Affected: n/a n/a

References

Link	Tags
http://www.waraxe.us/index.php?modname=sa&id=29	exploit
http://www.osvdb.org/6226	vdb entry
http://www.securityfocus.com/bid/10367	vdb entry exploit
http://marc.info/?l=bugtraq&m=108482957715299&w=2	mailing list
http://www.osvdb.org/6225	vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/16172	vdb entry
http://secunia.com/advisories/11625	third party advisory exploit

Frequently Asked Questions

What is the severity of CVE-2004-2020?: CVE-2004-2020 has been scored as a medium severity vulnerability.
How to fix CVE-2004-2020?: To fix CVE-2004-2020, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2004-2020 being actively exploited in the wild?: It is possible that CVE-2004-2020 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.